We are live on
!
Find out more
RCM
Raleigh Capital Management Portfolio holdings
AUM
$313M
1-Year Est. Return
23.55%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$192M
AUM Growth
+$21.2M
(+12%)
Cap. Flow
+$5.43M
Cap. Flow
% of AUM
2.82%
Top 10 Holdings %
Top 10 Hldgs %
19.8%
Holding
915
New
76
Increased
369
Reduced
163
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$1.36M |
| 2 |
Medtronic
MDT
|
+$1.02M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$927K |
| 4 |
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
|
+$874K |
| 5 |
Crown Castle
CCI
|
+$865K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.01M |
| 2 |
Chevron
CVX
|
+$861K |
| 3 |
ExxonMobil
XOM
|
+$817K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$696K |
| 5 |
Merck
MRK
|
+$685K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.54% |
| 2 | Healthcare | 10.29% |
| 3 | Consumer Staples | 9.47% |
| 4 | Energy | 7.21% |
| 5 | Utilities | 6.85% |
Similar funds
WMIG
JIC
FA
MIM
PAM
KA
SL
TF
Raleigh Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Raleigh Capital Management held 915 positions worth $192M, up 12% from $171M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Raleigh Capital Management's Q4 2022 filing shows 76 new, 369 increased, 163 reduced and 149 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M. The largest sale was Amgen, an estimated $1.01M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Staples.
- Raleigh Capital Management's largest Q4 2022 buy was iShares 0-3 Month Treasury Bond ETF: 13,550 shares worth $1.36M.
- Raleigh Capital Management added most to Medtronic in Q4 2022, an estimated $1.02M increase.
- Raleigh Capital Management's biggest Q4 2022 reduction was Amgen, cutting an estimated $1.01M.
- Raleigh Capital Management fully exited iShares Core High Dividend ETF in Q4 2022, selling an estimated $454K.
- Raleigh Capital Management's ten largest holdings make up 20% of its $192M portfolio in Q4 2022.
- Raleigh Capital Management opened 76 new positions and closed 149 in Q4 2022.
- Raleigh Capital Management's portfolio value rose 12% quarter-over-quarter to $192M.
Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.